IL92586A - History of 5-hydroxy and 5-methoxy-2-aminopyrimidines as inhibitors of interleukin-1 formation - Google Patents
History of 5-hydroxy and 5-methoxy-2-aminopyrimidines as inhibitors of interleukin-1 formationInfo
- Publication number
- IL92586A IL92586A IL9258689A IL9258689A IL92586A IL 92586 A IL92586 A IL 92586A IL 9258689 A IL9258689 A IL 9258689A IL 9258689 A IL9258689 A IL 9258689A IL 92586 A IL92586 A IL 92586A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- pharmaceutically
- acceptable salt
- interleukin
- mammal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28450588A | 1988-12-14 | 1988-12-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL92586A0 IL92586A0 (en) | 1990-08-31 |
IL92586A true IL92586A (en) | 1994-06-24 |
Family
ID=23090453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9258689A IL92586A (en) | 1988-12-14 | 1989-12-07 | History of 5-hydroxy and 5-methoxy-2-aminopyrimidines as inhibitors of interleukin-1 formation |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0373827B1 (fr) |
JP (1) | JPH0651622B2 (fr) |
KR (1) | KR920003578B1 (fr) |
AT (1) | ATE96321T1 (fr) |
AU (1) | AU605702B2 (fr) |
CA (1) | CA2005196A1 (fr) |
DE (1) | DE68910288T2 (fr) |
HU (1) | HU206182B (fr) |
IE (1) | IE893978L (fr) |
IL (1) | IL92586A (fr) |
PH (1) | PH27120A (fr) |
PT (1) | PT92551A (fr) |
ZA (1) | ZA899508B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5356898A (en) * | 1991-01-31 | 1994-10-18 | Warner-Lambert Company | Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines |
US5248682A (en) * | 1991-01-31 | 1993-09-28 | Warner-Lambert Company | 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
DE102004054080A1 (de) * | 2004-11-09 | 2006-05-11 | Wella Ag | Haut- oder Haarbehandlungsmittel mit Schutzeffekt |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670536B2 (de) * | 1966-11-09 | 1975-05-28 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Neue 2-Anilino-5-acylamino-pyrimidlne |
US4554276A (en) * | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
US4711888A (en) * | 1985-07-24 | 1987-12-08 | Pfizer Inc. | Hydroxy and alkoxy pyrimidines |
-
1989
- 1989-12-07 AT AT89312736T patent/ATE96321T1/de not_active IP Right Cessation
- 1989-12-07 DE DE89312736T patent/DE68910288T2/de not_active Expired - Fee Related
- 1989-12-07 IL IL9258689A patent/IL92586A/en not_active IP Right Cessation
- 1989-12-07 EP EP89312736A patent/EP0373827B1/fr not_active Expired - Lifetime
- 1989-12-11 PH PH39661A patent/PH27120A/en unknown
- 1989-12-11 JP JP1321232A patent/JPH0651622B2/ja not_active Expired - Lifetime
- 1989-12-12 CA CA002005196A patent/CA2005196A1/fr not_active Abandoned
- 1989-12-12 PT PT92551A patent/PT92551A/pt not_active Application Discontinuation
- 1989-12-12 AU AU46130/89A patent/AU605702B2/en not_active Ceased
- 1989-12-13 KR KR1019890018435A patent/KR920003578B1/ko not_active IP Right Cessation
- 1989-12-13 ZA ZA899508A patent/ZA899508B/xx unknown
- 1989-12-13 IE IE893978A patent/IE893978L/xx unknown
- 1989-12-13 HU HU896526A patent/HU206182B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA899508B (en) | 1991-07-31 |
KR920003578B1 (ko) | 1992-05-04 |
HU206182B (en) | 1992-09-28 |
EP0373827A3 (fr) | 1991-11-06 |
KR900009078A (ko) | 1990-07-02 |
JPH0651622B2 (ja) | 1994-07-06 |
EP0373827B1 (fr) | 1993-10-27 |
DE68910288T2 (de) | 1994-02-17 |
DE68910288D1 (de) | 1993-12-02 |
JPH02218613A (ja) | 1990-08-31 |
IL92586A0 (en) | 1990-08-31 |
PH27120A (en) | 1993-03-16 |
CA2005196A1 (fr) | 1990-06-14 |
IE893978L (en) | 1990-06-14 |
AU4613089A (en) | 1990-07-19 |
HUT51897A (en) | 1990-06-28 |
PT92551A (pt) | 1990-06-29 |
EP0373827A2 (fr) | 1990-06-20 |
ATE96321T1 (de) | 1993-11-15 |
AU605702B2 (en) | 1991-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930003912A (ko) | 울혈성 심장 마비 치료법 | |
KR20020015334A (ko) | 항균제로서의 화합물의 신규한 용도 | |
KR20010015807A (ko) | 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘에프1을 이용한 말초 혈관 질환의 치료 | |
EP0486809A2 (fr) | Utilisation de la suramine contre des maladies relatées au TNF | |
US4853409A (en) | 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function | |
KR0179315B1 (ko) | 알츠하이머병 치료용 약제 | |
IL92586A (en) | History of 5-hydroxy and 5-methoxy-2-aminopyrimidines as inhibitors of interleukin-1 formation | |
AU744492B2 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
US5352676A (en) | Morphalinomethyl-substituted 1-phenyl-indero-[1,2-c]pyrazol-3-yl derivatives of 2-cyano-3-oxo-propanamides useful in the treatment of rheumatoid arthritis | |
EP0337627B1 (fr) | Dérivés du 2-oxindole-1-carboxamide, substitués en position 3, utilisés comme inhibiteurs de la biosynthèse de l'interleukine-1 | |
KR900017577A (ko) | 폴리아민 유도체를 사용하여 세포- 중재의 면역성을 상승시키는 방법 | |
JPH0640915A (ja) | 自己免疫疾患処置のための医薬組成物 | |
WO1992003130A1 (fr) | Utilisation de composes d'aryle hydroxyuree pour le traitement de l'atherosclerose | |
CA2332427A1 (fr) | Agoniste du recepteur ep4 de la prostaglandine et traitement correspondant | |
EP0425109B1 (fr) | Dérivés de 3-substitués-2-oxindole comme inhibiteurs de biosynthèse d'interleukine | |
US5071852A (en) | Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production | |
US5260328A (en) | Phenyl-indenopurazol 3-oxo-propanamide derivatives useful in the treatment of rheumatoid arthritis | |
JPH0678230B2 (ja) | 好中球によるエラスターゼの遊離の阻害剤としてのテニダップ | |
CA2432504A1 (fr) | Methodes et compositions de traitement d'une parodontopathie | |
US5461072A (en) | Use of aryl hydroxyurea compounds for the treatment of atherosclerosis | |
EP1553938B1 (fr) | Utilisation de derives d'epothilone pour le traitement de l'hyperparathyroidie | |
BG100385A (bg) | Използване на бензидамин за лечение на патологични състояния, причинени от туморнекрозен фактор | |
US5310749A (en) | Antiprotozoal composition containing a 2-nitroimidazole derivative and method thereof | |
NZ235638A (en) | The use of indole derivatives for treating interleukin-1 related disorders | |
CA2156120A1 (fr) | Derives de substitution en 3 de 2-oxindoles, inhibiteurs de la replication virale |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |